Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -244,166 | -185,341 | -143,189 | -49,389 | -266,759 |
| Depreciation Amortization | 12,750 | 9,697 | 6,506 | 3,649 | 15,500 |
| Accounts payable and accrued liabilities | -3,545 | -3,356 | -2,999 | -4,224 | 1,377 |
| Other Working Capital | -10,114 | -13,528 | -14,225 | -10,858 | -1,185 |
| Other Operating Activity | 101,247 | 81,341 | 72,149 | 12,165 | 27,914 |
| Operating Cash Flow | $-143,828 | $-111,187 | $-81,758 | $-48,657 | $-223,153 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 494 | 706 | 611 | 117 | -33,430 |
| Purchase Of Investment | -87,293 | -51,209 | -1,682 | -1,682 | -226,064 |
| Sale Of Investment | 46,561 | 26,761 | 25,354 | 18,168 | 276,947 |
| Investing Cash Flow | $-40,238 | $-23,742 | $24,283 | $16,603 | $17,453 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -347 | -258 | -171 | -85 | 7,744 |
| Common Stock Issued | 129,080 | 111,341 | 1,714 | 1,067 | 192,005 |
| Financing Cash Flow | $128,733 | $111,083 | $1,543 | $982 | $199,749 |
| Beginning Cash Position | 131,398 | 131,398 | 131,398 | 131,398 | 137,349 |
| End Cash Position | 76,065 | 107,552 | 75,466 | 100,326 | 131,398 |
| Net Cash Flow | $-55,333 | $-23,846 | $-55,932 | $-31,072 | $-5,951 |
| Free Cash Flow | |||||
| Operating Cash Flow | -143,828 | -111,187 | -81,758 | -48,657 | -223,153 |
| Capital Expenditure | -938 | -65 | -24 | -136 | -33,430 |
| Free Cash Flow | -144,766 | -111,252 | -81,782 | -48,793 | -256,583 |